Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

CRC × spartalizumab × Gastrointestinal × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 22 Colorectal Neoplasms 19 Pancreatic Neoplasms 15 Stomach Neoplasms 14 Rectal Neoplasms 9 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Carcinoma, Non-Small-Cell Lung 6 Locally Advanced Rectal Cancer 5 Liver Neoplasms 5 Cholangiocarcinoma 5 Carcinoma, Renal Cell 5 Sarcoma 4 Melanoma 4 Lung Neoplasms 4 Gastrointestinal Stromal Tumors 4 Endometrial Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Neoplasms 2 Mesothelioma 2

Interventions

spartalizumab 1 Radiosurgery 1 Oncolytic Virotherapy 1 Leucovorin 1 Irinotecan 1 IFL protocol 1 Fluorouracil 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07381309 2026-02-02

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡